Activest Wealth Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$100K Buy
+620
New +$103K 0.02% 181
2026
Q2
– Sell
-18
Closed -$3.55K – 1350
2026
Q1
$3.55K Hold
18
– – ﹤0.01% 878
2025
Q4
$3.31K Buy
+18
New +$3.16K ﹤0.01% 823
2024
Q1
– Hold
0
– – – 366
2021
Q3
– Sell
-221
Closed -$26K – 387
2021
Q2
$26K Hold
221
– – 0.02% 130
2021
Q1
$22K Buy
+221
New +$22.2K 0.02% 141

Other funds holding AZN

Activest Wealth Management's AZN Position: Q3 2026 in Review

Activest Wealth Management opened a new position in AstraZeneca (AZN) in Q3 2026: 620 shares worth $100K. The stake represents 0.02% of the portfolio and ranks #181 among its holdings. This is a return to the name: Activest Wealth Management previously reported a position in AZN as recently as Q1 2026.

Activest Wealth Management first reported a position in AZN in Q1 2021 and has held it in 5 quarters since. 1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Activest Wealth Management held 620 shares of AstraZeneca worth $100K as of Q3 2026.
  • AstraZeneca was a new Activest Wealth Management position in Q3 2026.
  • AstraZeneca made up 0.02% of Activest Wealth Management's portfolio in Q3 2026, its #181 holding.
  • Activest Wealth Management first reported a position in AstraZeneca in Q1 2021 and has held it in 5 quarters since.
  • 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.